India to France: Amlodipine Export Trade Route
India has recorded 873 verified shipments of Amlodipine exported to France, representing a combined trade value of $15.6M USD. This corridor is served by 60 active Indian exporters, with an average shipment value of $17.9K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 12% of total export value with 53 shipments worth $1.9M USD. On the buying side, PLANET PHARMA is the largest importer in France with $1.5M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED — together control 31% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to France Amlodipine corridor is one of India's established pharmaceutical export routes, with 873 shipments documented worth a combined $15.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 12% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 60 active suppliers, the average shipment value stands at $17.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 23.8%, placing it at rank #7 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in France include PLANET PHARMA, PLANET PHARMA SA, CENTRE SPECIALITES PHARMACEUTIQUES and 94 others. PLANET PHARMA is the single largest importer with 174 shipments valued at $1.5M USD.
